STOCK TITAN

Waters Corp - WAT STOCK NEWS

Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.

Waters Corporation (NYSE: WAT) is a global leader in the field of analytical instruments and software solutions. For nearly six decades, the company has pioneered advancements in chromatography, mass spectrometry, and thermal analysis, catering to life, materials, and food sciences. Headquartered in Milford, Massachusetts, Waters Corp. operates directly in 35 countries, supported by approximately 8,000 employees and 15 manufacturing facilities globally.

Waters' main business segments include Waters, TA Instruments, VICAM, ERA, and Nonlinear Dynamics. The company's diverse product portfolio features ultra-performance liquid chromatography (UPLC), high-performance liquid chromatography (HPLC), chromatography columns, mass spectrometry systems, and laboratory informatics solutions. These innovations empower laboratory-dependent organizations to achieve advancements in healthcare, environmental management, food safety, and water quality.

Waters Corporation serves a wide array of customers, including biopharmaceutical companies (57% of sales), industrial clients (31% of sales), and academic/government institutions (12% of sales). The company’s products are available in over 100 countries, ensuring a broad market reach.

Recent achievements include the launch of new accessories for TA Instruments Discovery Hybrid Rheometers, designed for battery formulation analysis, and the introduction of Oasis WAX/GCB and GCB/WAX Cartridges for PFAS analysis. These innovations reflect the company’s commitment to addressing emerging scientific challenges and regulatory requirements. Additionally, Waters continues to enhance its mass spectrometry capabilities with products like the ACQUITY QDa II Mass Detector and the Xevo MRT MS, aimed at accelerating research in pharmaceuticals, food, chemicals, and materials.

Financially, Waters Corporation reported first-quarter 2024 sales of $637 million, with a strategic focus on innovation and operational efficiency. Despite a 7% decrease in sales compared to the previous year, the company remains optimistic about future growth, driven by new product launches and higher growth areas.

Waters Corporation stands as a pivotal player in the analytical instruments industry, consistently driving scientific advancements and operational excellence.

Rhea-AI Summary

Waters Corporation (NYSE:WAT) announced that its President and CEO, Udit Batra, will take part in a fireside chat at the Cowen Healthcare Conference on March 6, 2023, at 9:50 AM Eastern Time. A live webcast will be accessible via Waters’ investor relations website, and a replay will be available for 30 days after the event. Waters Corporation is a leader in analytical instruments and software, specializing in chromatography, mass spectrometry, and thermal analysis, with over 8,200 employees globally and operations in more than 35 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
none
-
Rhea-AI Summary

Waters Corporation (NYSE: WAT) reported fourth-quarter 2022 sales of $859 million, reflecting a 3% increase as reported and 9% in constant currency compared to Q4 2021. The full-year 2022 sales reached $2.97 billion, up 7% as reported and 12% in constant currency. Diluted EPS rose to $3.81 in Q4 2022 from $3.52 in Q4 2021. The company anticipates 2023 organic sales growth of 5% to 6.5% and non-GAAP EPS between $12.55 and $12.75, including a 3% foreign exchange headwind. Additionally, Waters announced the acquisition of Wyatt Technology for $1.36 billion, expected to close in Q2 2023, which will enhance its growth strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
-
Rhea-AI Summary

Waters Corporation (NYSE:WAT) has announced the acquisition of Wyatt Technology for $1.36 billion. This strategic move is aimed at enhancing Waters’ growth by expanding its presence in high-growth adjacent markets, particularly in bioanalytical characterization related to cell and gene therapies. The acquisition is expected to be accretive to revenue and adjusted earnings per share starting Q1 2024, with projected revenue synergies exceeding $70 million by year five. Wyatt, with 2022 revenues of $110 million, brings significant expertise in light scattering technology, further bolstering Waters' analytical solutions portfolio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
Rhea-AI Summary

Waters Corporation (NYSE:WAT) has launched the waters_connect System Monitoring application, a cloud-native Software-as-a-Service (SaaS) solution for real-time remote monitoring of chromatography instruments using Empower Software. This innovative tool enhances laboratory efficiency by providing immediate visibility into instrument availability, enabling quick response to changing priorities. It primarily targets high-volume QA/QC laboratories, assisting in reducing product release sample turnaround times and optimizing resource usage. The application is currently available in Europe and North America.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
none
-
Rhea-AI Summary

Waters Corporation (NYSE:WAT) will hold its Q4 2022 financial results conference call on February 15, 2023, at 8:00 a.m. eastern time. The live webcast can be accessed on their investor relations website. A replay will be available until March 1, 2023. Waters is a leader in analytical instruments and software, specializing in chromatography, mass spectrometry, and thermal analysis, with over 7,800 employees and operations in more than 35 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
none
Rhea-AI Summary

Waters Corporation (NYSE:WAT) will present at the J.P. Morgan Healthcare Conference on January 9, 2023, at 4:30 PM PST. Udit Batra, CEO, will discuss key topics with investors. The event can be accessed via a live webcast on Waters' investor relations website, with a replay available for 30 days. Waters has been a leader in analytical instruments and software for over 60 years, specializing in chromatography and mass spectrometry, with a presence in over 100 countries and more than 7,800 employees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
none
-
Rhea-AI Summary

Waters Corporation (NYSE:WAT) has appointed Dan Brennan and Mark Vergnano to its Board of Directors, effective November 23, 2022. Brennan, currently CFO at Boston Scientific, and Vergnano, former CEO of The Chemours Company, bring extensive experience crucial for Waters' growth strategy. Their addition follows a robust board refreshment process, making the board nine members strong, with eight independent. Chairman Dr. Flemming Ornskov highlights their potential to enhance operational and financial expertise as Waters implements its growth initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
management
Rhea-AI Summary

Waters Corporation has launched a new PFAS quantitation workflow that simplifies the detection of Per- and Polyfluoroalkyl Substances (PFAS) in various environmental samples. This end-to-end solution can measure parts-per-quadrillion (ppq) levels, exceeding regulatory limits, and includes automated data processing through the waters_connect software. This innovation aims to streamline laboratory operations while reducing manual errors in PFAS measurement, addressing increasing regulatory requirements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.36%
Tags
none

FAQ

What is the current stock price of Waters (WAT)?

The current stock price of Waters (WAT) is $368.16 as of December 20, 2024.

What is the market cap of Waters (WAT)?

The market cap of Waters (WAT) is approximately 21.7B.

What industries does Waters Corporation serve?

Waters Corporation serves biopharmaceutical, industrial, and academic/government sectors, providing analytical instruments and software solutions.

What are some of Waters Corporation's recent product launches?

Recent launches include the ACQUITY QDa II Mass Detector, Xevo MRT MS, and Oasis WAX/GCB Cartridges for PFAS analysis.

How does Waters Corporation contribute to scientific advancements?

Waters Corporation pioneers innovations in chromatography, mass spectrometry, and thermal analysis, enabling significant progress in healthcare, environmental management, food safety, and water quality.

What is the significance of the TA Instruments Discovery Hybrid Rheometers?

These rheometers are designed to enable simultaneous electrical impedance and rheological measurements, critical for optimizing battery formulations.

How is Waters Corporation performing financially?

In the first quarter of 2024, Waters Corporation reported sales of $637 million, focusing on innovation and operational efficiency to drive future growth.

Where is Waters Corporation headquartered?

Waters Corporation is headquartered in Milford, Massachusetts, and operates directly in 35 countries.

How many employees does Waters Corporation have?

Waters Corporation employs approximately 8,000 people worldwide.

What are TA Instruments' main products?

TA Instruments specializes in thermal analysis and rheometry solutions, supporting advancements in various scientific fields.

What is the significance of the Oasis WAX/GCB Cartridges?

These cartridges streamline the sample preparation process for PFAS analysis, ensuring accuracy and reducing processing time.

How can I access Waters Corporation's financial results?

Waters Corporation's financial results can be accessed through their Investor Relations website, where live webcasts and replays of financial presentations are available.

Waters Corp

NYSE:WAT

WAT Rankings

WAT Stock Data

21.70B
59.34M
0.05%
96.81%
3.51%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States of America
MILFORD